Publication date February 20, 2026. A large scale prospective cohort study from China examines how diagnostic and therapeutic management models relate to prognosis in intrauterine adhesions. The study is supported by The Third Xiangya Hospital of Central South University, Changsha Jiangwan Maternity Hospital, and Maternity and Child Health Hospital of Changsha. Interventions under evaluation include transcervical resection of adhesion, use of a uterine cavity stent, and Traditional Chinese medicine for tonifying the kidney. The trial is registered on ClinicalTrials.gov under identifier NCT07421908 and is currently recruiting. The information below outlines what changed, who should care, and how regulators may view these findings.
What changed in management models and regulatory relevance?
The study seeks to quantify associations between the diagnostic pathways and the chosen therapeutic strategies and the prognosis of intrauterine adhesions. Intrauterine adhesions can affect reproductive outcomes and uterine function. The trial spans three management components: a surgical procedure to remove adhesions, postoperative retention strategies and adjunct therapies. The use of a large prospective design supports regulatory minded assessment of real world performance and safety signals during routine care. These data may inform future guidelines and device evaluation strategies related to uterine cavity devices and surgical tools used in adhesion management. Sponsors listed include The Third Xiangya Hospital of Central South University, Changsha Jiangwan Maternity Hospital, and Maternity and Child Health Hospital of Changsha. The study status is Recruiting and the ClinicalTrials.gov record NCT07421908 is the public reference. For readers seeking the official protocol, the link to the trial registry is https://clinicaltrials.gov/study/NCT07421908?term=medical+device.
Who is affected by these findings?
Clinicians who treat intrauterine adhesions may adjust surgical and postoperative plans based on observed associations between management models and prognosis. Regulators assessing safety and performance of uterine cavity devices and surgical tools will want to see how these management strategies influence outcomes. Device manufacturers may use the trial results to inform risk assessments labeling decisions and postmarket surveillance strategies. This study highlights a specific combination of a surgical procedure, a device for postoperative support and an adjunct therapy that is sometimes used in care pathways. Observers should track how the outcomes are defined and what endpoints are used to measure prognosis.
What interventions are studied?
Transcervical resection of adhesion
This surgical procedure is included as a core component of the management models under study. It involves removal of adhesions from the uterine cavity with the aim of improving fertility prospects and pregnancy outcomes. The trial may monitor immediate safety signals and longer term reproductive results to inform device and procedure related performance.
Uterine cavity stent
A medical device used to maintain separation of the cavity after adhesion removal. The study will examine its role in prognosis and postoperative healing, including potential device related adverse effects and user dependent factors. Regulators will look at device properties that influence safety and effectiveness when used in this clinical setting.
Traditional Chinese medicine for tonifying the kidney
As an adjunct therapy included in the model, traditional chinese medicine is not a device. The study notes how this component is integrated with surgical and device based care. Regulators will consider how non device therapies contribute to overall prognosis and how combined modalities are evaluated in trials.
Sponsors and recruiting
The Third Xiangya Hospital of Central South University, Changsha Jiangwan Maternity Hospital, and Maternity and Child Health Hospital of Changsha are sponsors. The trial is currently Recruiting, indicating ongoing enrollment and data collection in a multicenter environment. This status supports timely collection of diverse outcomes that can inform regulatory evaluation of devices used in uterine cavity management.
Where to read more
The ClinicalTrials.gov record provides official details including protocol and enrollment updates. See the public registry at https://clinicaltrials.gov/study/NCT07421908?term=medical+device.
What are regulatory implications?
The association between diagnostic and therapeutic management models and prognosis in intrauterine adhesions can guide oversight of devices and procedures used in this condition. Regulators may consider how real world data from this trial informs risk management device labeling and postmarket surveillance for uterine cavity devices and related instruments. The described combination of a surgical procedure a cavity stent and an adjunct therapy reflects a mixed modality care pathway that may require integrated assessment in future guidelines. All manufacturer statements are presented as information and the sponsor or investigators should be consulted for formal regulatory positions.
- 1. What is the focus of this study
The study examines how diagnostic and therapeutic management models relate to prognosis in intrauterine adhesions.
- 2. Which interventions are studied
The trial evaluates transcervical resection of adhesion a uterine cavity stent and Traditional Chinese medicine for tonifying the kidney.
- 3. Where can I read more
The trial is registered on ClinicalTrials.gov under NCT07421908 with the link provided in the article.
- 4. What should regulators watch for
Regulators will assess safety and performance data related to the uterine cavity stent and the procedural approach in a real world context.
In summary the study aims to illuminate how management choices influence prognosis in intrauterine adhesions and how device based interventions fit into this picture. For stakeholders the key action is to review the trial registry monitor published results and prepare regulatory assessments that reflect real world practice and diverse patient populations.
This information is for professional use only. It is not legal advice and does not constitute regulatory guidance. Always consult official MDR and local regulatory requirements for device evaluation and approvals.
https://clinicaltrials.gov/study/NCT07421908?term=medical+device